Biosante Pharmaceuticals shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Biosante Pharmaceuticals by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $139k | 1.5k | 91.60 |
| 2025-06-30 | $118k | 1.8k | 65.25 |
| 2025-03-31 | $121k | 1.8k | 66.95 |
| 2024-12-31 | $100k | 1.8k | 55.28 |
| 2024-09-30 | $108k | 1.8k | 59.66 |
| 2024-06-30 | $115k | 1.8k | 63.68 |
| 2024-03-31 | $101k | 1.5k | 69.13 |
| 2023-12-31 | $80k | 1.5k | 55.14 |
| 2023-09-30 | $85k | 1.5k | 58.06 |
| 2023-06-30 | $55k | 1.0k | 53.83 |
| 2023-03-31 | $41k | 1.0k | 39.72 |
| 2022-12-31 | $44k | 1.0k | 42.98 |
| 2022-09-30 | $25k | 781 | 32.01 |
| 2022-06-30 | $23k | 781 | 29.45 |
| 2022-03-31 | $22k | 781 | 28.17 |
| 2021-12-31 | $36k | 781 | 46.09 |
| 2021-09-30 | $26k | 781 | 33.29 |
| 2021-06-30 | $27k | 781 | 34.57 |
| 2021-03-31 | $28k | 781 | 35.85 |
| 2020-12-31 | $23k | 781 | 29.45 |
| 2020-09-30 | $22k | 781 | 28.17 |
| 2020-06-30 | $25k | 781 | 32.01 |
| 2020-03-31 | $32k | 781 | 40.97 |
| 2019-12-31 | $48k | 781 | 61.46 |
| 2019-09-30 | $57k | 781 | 72.98 |
| 2019-06-30 | $64k | 781 | 81.95 |
| 2019-03-31 | $43k | 616 | 69.81 |
| 2018-12-31 | $28k | 616 | 45.45 |
| 2018-09-30 | $35k | 616 | 56.82 |
| 2018-06-30 | $41k | 616 | 66.56 |
| 2018-03-31 | $36k | 616 | 58.44 |
| 2017-12-31 | $40k | 616 | 64.94 |
| 2017-09-30 | $29k | 616 | 47.08 |
| 2017-06-30 | $29k | 616 | 47.08 |
| 2017-03-31 | $30k | 616 | 48.70 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors